Figure 1 Response in patients with evaluable disease demonstrated in spider plot ( a ) and waterfall plot ( b ). * The patient with PD (in bluemost left) had RECIST measurement of +17%, which qualifies as SD but also had unequivocal progression of nontarget lesions. More about this image found in Response in patients with evaluable disease demonstrated in spider plot ( a...

Figure 1 Study schema and patient disposition. More about this image found in Study schema and patient disposition.

Figure 2 (A) Best change in sum of target lesion diameters from baseline and programmed-death ligand 1 (PD-L1) tumor expression status across 36 subjects in the cholangiocarcinoma cohort with postbaseline assessments. (B) Progression-free survival in the cholangiocarcinoma cohort. More about this image found in (A) Best change in sum of target lesion diameters from baseline and program...

Figure 1 Expert recommendations on the prednisone dose for immune-related inflammatory arthritis. More about this image found in Expert recommendations on the prednisone dose for immune-related inflammato...

Figure 2 Expert recommendations on use of disease-modifying antirheumatic drugs and steroid-sparing agents after steroid failure in immune-related inflammatory arthritis. More about this image found in Expert recommendations on use of disease-modifying antirheumatic drugs and ...

Figure 1 Flowchart of study selection according to PRISMA guidelines. More about this image found in Flowchart of study selection according to PRISMA guidelines.

Figure 1 CT images of BRAF V600E/MSI-H case. CT images of the abdomen and pelvis illustrate the recurrent primary tumor surrounding the cecum (red arrow) and malignant pericolic lymphadenopathy (yellow arrow). Serial imaging studies at 2, 6, and 120 months show excellent, durable response to tre... More about this image found in CT images of BRAF V600E/MSI-H case. CT images of the abdomen and pelvis i...

Figure 1 Cyclin-dependent kinases (CDKs) and their subunits contribute to the regulation of the cell cycle. CDK3/cyclin C drives cell cycle entry from G0. The CDK4/6/cyclin D initiates phosphorylation of the retinoblastoma protein (pRb). In late G1, the CDK2/cyclin E complex completes the phosphor... More about this image found in Cyclin-dependent kinases (CDKs) and their subunits contribute to the regula...

Figure 1 Cadherin function and disease relevance. (A) The cell-cell interaction of classical cadherins. E-cadherin (green) and N-cadherin (red) both have highly conserved cytoplasmic tails that bind to alpha and beta-catenin and anchor to the actin cytoskeleton. Each cadherin will then form a dime... More about this image found in Cadherin function and disease relevance. (A) The cell-cell interaction of c...

Figure 1 Overall survival for cohort. More about this image found in Overall survival for cohort.

Figure 2 Progression-free survival for overall cohort. More about this image found in Progression-free survival for overall cohort.